Law Offices of Thomas J. Lamb

  • Asbestos & Mesothelioma
  • Benzene Diseases
  • Camp Lejeune Cases
  • Drug Injury
  • Free Case Evaluation
  • About Us

Pancreatic Cancer: Side Effect Of Onglyza, Nesina, Tradjenta, Other DPP-4 Inhibitor Diabetes Drugs?

September 26, 2019 By Law Offices of Thomas J. Lamb, P.A.

There is new medical research concerning pancreatic cancer linked to diabetes medicines in the DPP-4 inhibitor drug class. In more detail, the use of dipeptidyl peptidase-4 inhibitors (DPP-4i) diabetes medicines may be associated with an increased risk for pancreatic cancer in patients with newly diagnosed type 2 diabetes. This finding comes … [Read more...]

Filed Under: Unsafe Drugs Tagged With: diabetes drugs, diabetes drugs side effects, drug side effects, Nesina, Onglyza, Pancreatic Cancer, Tradjenta

Cases Of Fournier Gangrene Associated With Diabetes Drugs Invokana, Jardiance, And Farxiga

May 9, 2019 By Law Offices of Thomas J. Lamb, P.A.

The FDA has identified 55 unique cases of Fournier gangrene associated with diabetes drugs in the Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors class between March 1, 2013 and January 31, 2019. Of those Fournier gangrene cases, 21 cases were associated with Invokana (canagliflozin), 18 cases were associated with Jardiance (empagliflozin), and … [Read more...]

Filed Under: Unsafe Drugs Tagged With: diabetes drugs, diabetes drugs side effects, Farxiga, Fournier’s Gangrene, Invokana, Jardiance, sglt2 inhibitors diabetes drugs

Lower Limb Amputations From All SGLT2 Inhibitors, or Just Invokana?

January 9, 2019 By Law Offices of Thomas J. Lamb, P.A.

A “Black-Box Warning” about the increased risk of lower limb amputations was added to the drug labels for Invokana and Invokamet in July 2017. Since that time there has been a mix of opinions expressed in the medical literature about whether or not lower limb amputations are a side effect of all diabetes medicines in the sodium-glucose … [Read more...]

Filed Under: Unsafe Drugs Tagged With: diabetes drugs, drug injury lawsuits, drug side effects, Farxiga, Invokamet, Invokana, Jardiance, lower limb amputations

Certain Diabetes Drugs Like Januvia Associated With Bile Duct Cancer

December 21, 2018 By Law Offices of Thomas J. Lamb, P.A.

The risk of developing bile duct cancer, also known as cholangiocarcinoma, is almost doubled for type 2 diabetics using one of the following diabetes medicines: Januvia (sitagliptin) Janumet (sitagliptin / metformin HCl) Onglyza (saxagliptin) Kombiglyze XR (saxagliptin and metformin) Qtern (dapagliflozin and saxagliptin) Nesina … [Read more...]

Filed Under: Unsafe Drugs Tagged With: bile duct cancer, cholangiocarcinoma, diabetes drugs, dpp-4 drugs, Glyxambi, Janumet, Januvia, Jentadueto, Kazano, Kombiglyze XR, Nesina, Onglyza, Oseni, Qtern, Tradjenta

Farxiga And Jardiance Have Two-Time Increased Risk For Amputations

November 23, 2018 By Law Offices of Thomas J. Lamb, P.A.

Patients using the diabetes drugs Farxiga and Jardiance had twice the risk for lower limb amputations relative to certain other diabetes medicines, according to a new observational study published in November 2018 by The BMJ medical journal in. However, in the US only a third diabetes drugs in the sodium-glucose cotransporter 2 (SGLT2) … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Amputations, diabetes drugs, drug injury, Farxiga, Invokamet, Invokana, Jardiance

Amputations Are Diabetes Drugs Side Effects For SGLT2 Inhibitors Class

November 7, 2018 By Law Offices of Thomas J. Lamb, P.A.

There seems to be an increasing degree of acknowledgement in the medical literature that these lower limb amputations are drug-class side effects of SGLT2 inhibitors class diabetes medicines such as Jardiance and Farxiga in addition to Invokana. For example, from this recent Medscape news report, “Canagliflozin (Invokana) Gets FDA Nod for CV … [Read more...]

Filed Under: Unsafe Drugs Tagged With: diabetes drugs, diabetes drugs amputation, drug side effects, Farxiga, Invokana, Jardiance, lower limb amputations

Fournier’s Gangrene: Side Effect For Invokana, Farxiga, And Jardiance

October 15, 2018 By Law Offices of Thomas J. Lamb, P.A.

From this August 29, 2018 Drug Safety Communication, “FDA warns about rare occurrences of a serious infection of the genital area with SGLT2 inhibitors for diabetes”, we get the following details about this new safety issue for Invokana, Farxiga, Jardiance, and similar diabetes drugs: Fournier’s gangrene is an extremely rare but life-threatening … [Read more...]

Filed Under: Unsafe Drugs Tagged With: diabetes drugs, drug injury, drug side effects, Farxiga, Fournier’s Gangrene, Invokana, Jardiance

Increased Risks Of Lower-Limb Amputations For Farxiga And Jardiance

September 5, 2018 By Law Offices of Thomas J. Lamb, P.A.

During late August a presentation at the 2018 European Society of Cardiology Congress in Munich, Germany included evidence that the SGLT-2 inhibitors Invokana, Jardiance, and Farxiga all are associated with twofold increases for lower-limb amputations when compared to GLP-1 receptor agonists diabetes drugs. An August 25, 2018 Healio.com article, … [Read more...]

Filed Under: Uncategorized, Unsafe Drugs Tagged With: Amputations, diabetes drugs, drug injury, Farxiga, Invokana, Jardiance

New Analysis Finds An Increased Risk Of Bladder Cancer For Jardiance

November 13, 2017 By Law Offices of Thomas J. Lamb, P.A.

This article, “SGLT2 inhibitors and risk of cancer in type 2 diabetes: a systematic review and meta-analysis of randomised controlled trials”, was published in the October 2017 edition of Diabetologia. It presents the findings of medical researchers who conducted a systematic literature review to identify randomized controlled trials that reported … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Bladder Cancer, diabetes drugs, diabetes drugs side effects, Glyxambi, Jardiance, Sodium-Glucose-Cotransporter-2 Inhibitors, Synjardy, Synjardy XR

SGLT2 Inhibitors May Have an Increased Risk of Acute Renal Failure

October 31, 2017 By Law Offices of Thomas J. Lamb, P.A.

SGLT2 Inhibitors: A New Side Effect In previous articles, I have discussed SGLT2 inhibitor diabetes drugs such as Invokana, Farxiga, and Jardiance and the adverse events associated with them.  Such side effects include diabetic ketoacidosis (DKA) and lower-limb amputations. A recent study identified a new possible side effect of these drugs … [Read more...]

Filed Under: Unsafe Drugs Tagged With: acute renal failure, ARF, diabetes drugs, diabetes drugs renal failure, diabetes drugs side effects, FAERS, Farxiga, FDA Adverse Event Report System Database, Glyxambi, Invokamet, invokamet xr, Invokana, Jardiance, Qtern, sglt2 inhibitors, Sodium-Glucose-Cotransporter-2 Inhibitors, Synjardy, Synjardy XR, type 2 diabetes drugs, xigduo xr

  • 1
  • 2
  • Next Page »

Find What You Want Here

Get Free Case Evaluation

We encourage you to submit an online Case Evaluation Form – it is confidential and there is no obligation.

Or call our toll-free number, 800-426-9535, to speak directly to attorney Tom Lamb about your possible case.

Feel Free To Contact Us

Quick Contact Form
 
Send an Email to Tom Lamb

(800) 426-9535

Main Navigation Menu

  • About Our Firm
  • Asbestos-Mesothelioma Cases
  • Benzene Disease Claims
  • Camp Lejeune Cases
  • GenX Water Cancer Cases
  • Drug Injury Lawsuits
  • Breast Implant Cancer Cases
  • Philips Breathing Devices Cases
  • Case Evaluation Menu
  • Quick Contact Form
  • Frequently Asked Questions
  • Medical Records Charges
  • Collection of Articles
  • Sitemap

Lamb Law Office Newsletter

Lamb Law Office Newsletter provides periodic updates about some of the cases that we are working on for clients, as well as an information resource you might find helpful.

Subscribe using Form below.

Subscription Form

* indicates required

Our Other Websites

Drug Injury Law
Drug Injury Watch
Drug Safety Developments
Asbestos & Mesothelioma

Contact Information

Law Offices of Thomas J. Lamb, P.A.
1908 Eastwood Road, Suite 225
Wilmington, North Carolina 28403
910-256-2971 | 800-426-9535
TJL@LambLawOffice.com

  • Home
  • Frequently Asked Questions
  • Disclaimer and Copyright Notices

Copyright © 2023 · Law Offices of Thomas J. Lamb, P.A.